Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

The introduction of Merilog is particularly notable given that it is the third insulin biosimilar approved in the U.S., following the approval of two long-acting insulin biosimilars in 2021.

An early-morning rise in blood sugar is common in people with diabetes. Find out more about why it happens and how to prevent ...

It is most effective at managing blood sugar overnight and between meals. While long-acting insulin is slow to reach the bloodstream and has a relatively low peak, it stabilizes the “plateau ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.